Tuesday, 22 Sep 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Finance
  • Clinical trial results
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Chia Tai Tianqing's Anlotinib Granted NMPA Approval for Soft Tissue Sarcoma
Others

Chia Tai Tianqing’s Anlotinib Granted NMPA Approval for Soft Tissue Sarcoma

July 1, 2025
Huadong Medicine's First-in-Class ADC HDM2012 Gains FDA Phase I Trial Clearance
CompanyDrug

Huadong Medicine’s First-in-Class ADC HDM2012 Gains FDA Phase I Trial Clearance

July 1, 2025
China Unveils Measures to Boost Innovative Drug Development With Insurance Data Support
Policy / Regulatory

China Unveils Measures to Boost Innovative Drug Development With Insurance Data Support

July 1, 2025
HutchMed's Orpathys Approved in China for EGFR-MET Co-Mutation NSCLC
CompanyDeals

HutchMed’s Orpathys Approved in China for EGFR-MET Co-Mutation NSCLC

July 1, 2025
Recbio Partners with Biological E for HPV VaccineREC603's India and Global Expansion
CompanyDeals

Recbio Partners with Biological E for HPV VaccineREC603’s India and Global Expansion

July 1, 2025
Astellas Pharma's Vyloy Gains First Prescriptions Across China for Gastric Cancer
CompanyDrug

Astellas Pharma’s Vyloy Gains First Prescriptions Across China for Gastric Cancer

July 1, 2025
Guangdong Announces First Batch of Approved Innovative Drugs and Medical Devices
Others

Guangdong Announces First Batch of Approved Innovative Drugs and Medical Devices

July 1, 2025
Santen's Tapcom Administered to First Patient in GBA via Drug Access Policy
CompanyDrug

Santen’s Tapcom Administered to First Patient in GBA via Drug Access Policy

July 1, 2025
Zhaoke Ophthalmology Partners with Jamjoom Pharma for Cyclosporine Eye Gel Distribution in Middle East
CompanyDeals

Zhaoke Ophthalmology Partners with Jamjoom Pharma for Cyclosporine Eye Gel Distribution in Middle East

July 1, 2025
Ascletis Faces Patent Challenge from CSPC Subsidiary Conjupro Bio
CompanyDrug

Ascletis Faces Patent Challenge from CSPC Subsidiary Conjupro Bio

July 1, 2025
Fosun Pharma Secures Licensing Deal for HCB101 SIRPα-Fc Fusion Protein
CompanyDeals

Fosun Pharma Secures Licensing Deal for HCB101 SIRPα-Fc Fusion Protein

July 1, 2025
Zai Lab's Bemarituzumab Meets Phase III Endpoint in Gastric Cancer Trial
CompanyDrug

Zai Lab’s Bemarituzumab Meets Phase III Endpoint in Gastric Cancer Trial

July 1, 2025
1 2 … 22 23 24 25
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up